HIGHLIGHTS
- who: Borut Polju0161ak et al. from the Laboratory of Oxidative Stress Research, Faculty of Health Sciences, University of have published the paper: Current Uncertainties and Future Challenges Regarding NAD+ Boosting Strategies, in the Journal: Antioxidants 2022, 11, 1637. of 25/07/2022
- what: Results from preclinical studies and preliminary results from small human clinical trials imply that promoting intracellular NAD+ anabolism through NAD+ boosters is a promising therapeutic strategy for age-associated degenerative diseases [96].
- future: Their role in cancer prevention and promotion must be fully elucidated in future studies. Future studies should . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.